ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsPresident's ThemeACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer Care
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
2024 Policy Wrap-Up and ACCC 2025 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportACCC Innovator AwardsACCC FellowsACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Fax: 301.770.1949 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
Home / Education And Resources / Patient Assistance And Reimbursement Guide / Companies / Novartis Pharmaceuticals Corporation

NOVARTIS PHARMACEUTICALS CORPORATION

Novartis Pharmaceuticals Corporation

Patient and Reimbursement Assistance

https://www.hcp.novartis.com/access/

Phone Number

1.800.282.7630

Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation offers the Patient Assistance Now Oncology (PANO) program to patients prescribed a qualifying Novartis product. PANO is the preferred first stop for access to Novartis Oncology Patient Support programs. Through one-on-one guidance with a dedicated case manager, patients will discover which Novartis Oncology Patient Support programs they are eligible to receive and may also be referred to other services.

For more information, search the prescribed Novartis product in this Guide, go online, call 1.800.282.7630, Monday through Friday, 8:00 AM to 8:00 PM EST.

Oncology-related products: Adakveo® (crizanlizumab-tmca) for IV infusion, Afinitor® (everolimus) tablets, Ellence® (epirubicin hydrochloride) injection, Exjade® (deferasirox) tablets for oral suspension, Femara® (letrozole) tablets, Gleevec® (imatinib mesylate) tablets, Jadenu® (deferasirox) tablets, Kisqali® (ribociclib) tablets, Kymriah® (tisagenlecleucel) suspension for IV Infusion, Mekinist® (trametinib) tablets, Piqray® (alpelisib) tablets, Pluvicto™ (lutetium Lu 177 vipivotide tetraxetan) injection for intravenous use, Promacta® (eltrombopag) tablets, Rydapt® (midostaurin) capsules, Sandostatin® (octreotide acetate) injection, Sandostatin® LAR Depot (octreotide acetate) for injectable suspension, Scemblix® (asciminib) tablets, Tabrecta™ (capmatinib) tablets, Tafinlar® (dabrafenib) capsules, Tasigna® (nilotinib) capsules, Tykerb® (lapatinib) tablets, Votrient® (pazopanib) tablets, Zometa® (zoledronic acid) for injection, Zykadia® (ceritinib) tablets

Reimbursement Assistance

AAA PatientConnect™

AAA PatientConnect is a patient-centric support program form Novartis' Avanced Accelerator Applications that is committed to delivering assistance for eligible patients, including

  • Benefits verification
  • Prior authorization information
  • Product ordering.

To enroll patients, go online or fax the completed enrollment form to 1.844.638.7329. Note: Enrollment cannot be processed without both the prescriber and patient signatures.

For support, call 1.844.638.7222, Monday through Friday, 8:00 AM to 8:00 PM EST.

Kymriah Cares®

Whether patients and providers have questions about Kymriah or insurance coverage, Kymriah Cares can help. The program can provide assistance with treatment center support, patient support, and coordination of care support.

To learn more, call 1.844.459.6742 from 8:00 AM to 8:00 PM EST.

Co-Pay Card/Out-Of-Pocket Cost Assistance

Novartis Oncology Universal Co-Pay Program

Novartis Oncology has made it easy for patients with private insurance to access financial support for their prescription co-pay costs on almost all Novartis Oncology medications. Eligible, privately insured patients may pay $25 per month and Novarits will pay the remaining co-pay, up to $15,000 per calendar year, per product.

The Novartis Oncology Universal Co-pay Program includes the co-pay card, payment card, or rebate with a combined annual limit of $15,000. Patients are responsible for any costs once the limit is reached in a calendar year.

This program is not available for patients who are enrolled in Medicare, Medicaid, or any other federal or state health care program. Novartis reserves the right to rescind, revoke, or amend this program without notice.

Find out if a patient is eligible to enroll in the program online or by calling 1.877.577.7756.

Patient Assistance Program

Novartis Patient Assistance Foundation, Inc.

This foundation may help provide access to Novartis medicines to patients experiencing financial hardship and/or have no third-party insurance coverage. Please be advised that access to the medicines distributed through the Novartis Patient Assistance Foundation, Inc., is free of charge to all eligible patients.

To be eligible, patients must:

  • Be a United States resident
  • Provide proof of income that meets financial eligibility requirements
  • Have limited or no prescription coverage. (Exceptions exist for individuals with limited prescription coverage.)

To enroll patients, submit the enrollment form online or fax the completed downloadable form to PANO at 1.800.282.7630.

For more information, call 1.800.277.2254.

Reimbursement Assistance

Patient Assistance Now Oncology (PANO)

Patient Assistance Now Oncology (PANO) is the preferred first stop for access to Novartis Oncology Patient Support programs. Through one-on-one guidance with a dedicated case manager, patients will discover which Novartis Oncology Patient Support programs they are eligible to receive and may also be referred to other services.

Support for patients includes:

  • Insurance benefits verification
  • Information on prior authorization
  • Information on denial appeals.

Enroll patients by completing and submitting the PANO Service Request Form online or via fax to 1.888.891.4924. To learn more call 1.800.282.7630, Monday through Friday, 8:00 AM to 8:00 PM EST.

Independent Charitable Foundations/Organizations

Patient Assistance Now Oncology (PANO) Referrals

Novartis can provide information about independent organizations that can assist with a patient's day-to-day needs. Independent charitable foundations may also be available to provide additional financial assistance to patients. To see a full list of organizations available, visit the PANO website.

All organizations are independent of Novartis Pharmaceuticals Corporation. Novartis has no financial interest in any organization listed but may provide occasional funding to these organizations.